Home > Resources > Whitepapers > Realising the potential of stratified medicine

Realising the potential of stratified medicine

Although patient treatment has always been personalised by clinicians based upon individual circumstance and medical history, advances in our understanding of the molecular basis of diseases are redefining how diseases are classified and present a powerful new dimension by which to tailor preventive measures or treatments to individuals further.

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Alina Combine Pharmaceuticals Pvt. Ltd.

Alina Combine Pharmaceuticals (Pvt) Ltd is one of Pakistan's premier Pharmaceutical & Veterinary Medicine manufacturing company following strict GMP guidelines. Our pharmaceutical manufacturing unit is well equipped and manned by highly qualified and experienced personnel. Our current range of products includes Water Soluble Powders, Liquids/Solutions, Liquid Injections in the Veterinary Department and a range of Human Pharmaceuticals in the form of Liquids, Tablets, Ointments, and Injections.

OTHER WHITEPAPERS
news image

The SwedishDrug Discovery and DevelopmentPipeline 2023

whitePaper | March 23, 2023

Sweden is and should remain a leading life sciences nation. The life sciences industry is one of Sweden’s economic base industries with a signifi cant share of our exports.

Read More
news image

Addressing Viral Pandemics Such as COVID-19 Using the Carterra® LSA

whitePaper | January 21, 2023

Emerging Diseases Require New Tools Medicines to treat and prevent infectious diseases cover a broad range of modalities from dosed therapeutics to vaccines. Biotherapeutics require a detailed knowledge of binding sites, or epitopes, on their respective antigens.

Read More
news image

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More
news image

Unlocking iPSCs to Improve CNS Modeling and Drug Discovery

whitePaper | June 15, 2022

To date, therapeutic advances in treating central nervous system (CNS) disorders have been incremental at best. As the global population increases and older demographics begin to make up a disproportionately larger percentage,

Read More
news image

Pharma R&D Annual Review

whitePaper | March 15, 2022

Successes in 2021 – New active substance drug launches

Read More
news image

Securing the modern pharmaceutical supply chain

whitePaper | April 22, 2022

Members of the Health-ISAC community have produced a security framework for the pharmaceutical supply chain comprising this CISO guide.

Read More

The SwedishDrug Discovery and DevelopmentPipeline 2023

whitePaper | March 23, 2023

Sweden is and should remain a leading life sciences nation. The life sciences industry is one of Sweden’s economic base industries with a signifi cant share of our exports.

Read More

Addressing Viral Pandemics Such as COVID-19 Using the Carterra® LSA

whitePaper | January 21, 2023

Emerging Diseases Require New Tools Medicines to treat and prevent infectious diseases cover a broad range of modalities from dosed therapeutics to vaccines. Biotherapeutics require a detailed knowledge of binding sites, or epitopes, on their respective antigens.

Read More

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More

Unlocking iPSCs to Improve CNS Modeling and Drug Discovery

whitePaper | June 15, 2022

To date, therapeutic advances in treating central nervous system (CNS) disorders have been incremental at best. As the global population increases and older demographics begin to make up a disproportionately larger percentage,

Read More

Pharma R&D Annual Review

whitePaper | March 15, 2022

Successes in 2021 – New active substance
drug launches

Read More

Securing the modern pharmaceutical supply chain

whitePaper | April 22, 2022

Members of the Health-ISAC community have produced a security framework for the pharmaceutical supply chain comprising this CISO guide. 

Read More
More Whitepapers

Spotlight

Alina Combine Pharmaceuticals Pvt. Ltd.

Alina Combine Pharmaceuticals (Pvt) Ltd is one of Pakistan's premier Pharmaceutical & Veterinary Medicine manufacturing company following strict GMP guidelines. Our pharmaceutical manufacturing unit is well equipped and manned by highly qualified and experienced personnel. Our current range of products includes Water Soluble Powders, Liquids/Solutions, Liquid Injections in the Veterinary Department and a range of Human Pharmaceuticals in the form of Liquids, Tablets, Ointments, and Injections.

Events

National Medtech & Biotech Summit 2024

Conference